Transcriptome sequencing in pediatric acute lymphoblastic leukemia identifies fusion genes associated with distinct DNA methylation profilesSpringer Science and Business Media LLC - Tập 10 - Trang 1-14 - 2017
Yanara Marincevic-Zuniga, Johan Dahlberg, Sara Nilsson, Amanda Raine, Sara Nystedt, Carl Mårten Lindqvist, Eva C. Berglund, Jonas Abrahamsson, Lucia Cavelier, Erik Forestier, Mats Heyman, Gudmar Lönnerholm, Jessica Nordlund, Ann-Christine Syvänen
Structural chromosomal rearrangements that lead to expressed fusion genes are a
hallmark of acute lymphoblastic leukemia (ALL). In this study, we performed
transcriptome sequencing of 134 primary ALL patient samples to comprehensively
detect fusion transcripts. We combined fusion gene detection with genome-wide
DNA methylation analysis, gene expression profiling, and targeted sequencing to
determi... hiện toàn bộ
Skeletal Plasmacytoma: Progression of disease and impact of local treatment; an analysis of SEER databaseSpringer Science and Business Media LLC - - 2009
Muhammad Umar Jawad, Sean P Scully
Previous reports suggest an as yet unidentifiable subset of patients with
plasmacytoma will progress to myeloma. The current study sought to establish the
risk of developing myeloma and determine the prognostic factors affecting the
progression of disease. Patients with plasmacytoma diagnosed between 1973 and
2005 were identified in the SEER database(1164 patients). Patient demographics
and clinic... hiện toàn bộ
Tumor organoids: applications in cancer modeling and potentials in precision medicineSpringer Science and Business Media LLC - - 2022
Hanxiao Xu, Dechao Jiao, Aiguo Liu, Kongming Wu
Cancer is a top-ranked life-threatening disease with intratumor heterogeneity.
Tumor heterogeneity is associated with metastasis, relapse, and therapy
resistance. These factors contribute to treatment failure and an unfavorable
prognosis. Personalized tumor models faithfully capturing the tumor
heterogeneity of individual patients are urgently needed for precision medicine.
Advances in stem cell c... hiện toàn bộ
Splicing factor 3b subunit 1 (Sf3b1) haploinsufficient mice display features of low risk Myelodysplastic syndromes with ring sideroblastsSpringer Science and Business Media LLC - Tập 7 - Trang 1-10 - 2014
Valeria Visconte, Ali Tabarroki, Li Zhang, Yvonne Parker, Edy Hasrouni, Reda Mahfouz, Kyoichi Isono, Haruhiko Koseki, Mikkael A Sekeres, Yogen Saunthararajah, John Barnard, Daniel Lindner, Heesun J Rogers, Ramon V Tiu
The presence of somatic mutations in splicing factor 3b subunit 1 (SF3B1) in
patients with Myelodysplastic syndromes with ring sideroblasts (MDS-RS)
highlights the importance of the RNA-splicing machinery in MDS. We previously
reported the presence of bone marrow (BM) RS in Sf3b1 heterozygous (Sf3b1+/−)
mice which are rarely found in mouse models of MDS. Sf3b1+/− mice were
originally engineered to... hiện toàn bộ
Drugging KRAS: current perspectives and state-of-art reviewSpringer Science and Business Media LLC - Tập 15 - Trang 1-22 - 2022
Kaushal Parikh, Giuseppe Banna, Stephen V. Liu, Alex Friedlaender, Aakash Desai, Vivek Subbiah, Alfredo Addeo
After decades of efforts, we have recently made progress into targeting KRAS
mutations in several malignancies. Known as the ‘holy grail’ of targeted cancer
therapies, KRAS is the most frequently mutated oncogene in human malignancies.
Under normal conditions, KRAS shuttles between the GDP-bound ‘off’ state and the
GTP-bound ‘on’ state. Mutant KRAS is constitutively activated and leads to
persiste... hiện toàn bộ
Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapySpringer Science and Business Media LLC -
Hui Wu, Yue Gong, Peng Ji, Yifan Xie, Yi‐Zhou Jiang, Guang-yu Liu
AbstractTargeting nucleotide metabolism can not only inhibit tumor initiation
and progression but also exert serious side effects. With in-depth studies of
nucleotide metabolism, our understanding of nucleotide metabolism in tumors has
revealed their non-proliferative effects on immune escape, indicating the
potential effectiveness of nucleotide antimetabolites for enhancing
immunotherapy. A growi... hiện toàn bộ
Recent advances in targeted strategies for triple-negative breast cancerSpringer Science and Business Media LLC -
Shuangli Zhu, Yuze Wu, Bin Song, Ming Yi, Yichao Yan, Qi Mei, Kongming Wu
AbstractTriple-negative breast cancer (TNBC), a highly aggressive subtype of
breast cancer, negatively expresses estrogen receptor, progesterone receptor,
and the human epidermal growth factor receptor 2 (HER2). Although chemotherapy
is the main form of treatment for patients with TNBC, the effectiveness of
chemotherapy for TNBC is still limited. The search for more effective therapies
is urgent. ... hiện toàn bộ